ClinicalTrials.govpublic full text
Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma
gastric carcinoma, liposomal paclitaxel, maximum tolerated dose, pharmacokinetics, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 866263
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.